RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
MARCHETTI M
Collezione ASL Asti
Items : 41
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. in The Lancet. Haematology / Lancet Haematol. 2024 Feb;11(2):e147-e159. doi: 10.1016/S2352-3026(23)00342-3. Epub 2024 Jan 3.
2024
ASL Asti
Penack O; Marchetti M; Aljurf M; Arat M; Bonifazi F; Duarte RF; Giebel S; Greinix H; Hazenberg MD; Kröger N; Mielke S; Mohty M; Nagler A; Passweg J; Patriarca F; Ruutu T; Schoemans H; Solano C; Vrhovac R; Wolff D; Zeiser R; Sureda A; Peric Z;
2023
ASL Asti
Caocci G; Palandri F; Loscocco GG; Tieghi A; Patriarca A; Iurlo A; Abruzzese E; Rossi E; Baldi T; Fava C; Beggiato E; Tomasetti S; Marchetti M; Vanni D; Fozza C; Luppi M; La Nasa G; Fazi P; Vignetti M; Vannucchi AM; Efficace F;
Comparative Clinical Value of Pharmacologic Therapies for B-Cell Chronic Lymphocytic Leukemia: An Umbrella Analysis. in Journal of clinical medicine / J Clin Med. 2022 Mar 28;11(7):1868. doi: 10.3390/jcm11071868.
2022
ASL Asti
AOU Alessandria
Bertassello C; Rivela P; Marchetti M; Canicattì M;
2022
ASL Asti
Caocci G; Palandri F; Loscocco GG; Piciocchi A; Iurlo A; Tieghi A; Patriarca A; Abruzzese E; Tomassetti S; Marchetti M; Vanni D; Luppi M; Pane F; Breccia M; Siragusa S; Elli EM; Ricco A; Fozza C; Corsetti MT; Fava C; Mazzoni C; Fazi P; La Nasa G; Vignetti M; Vannucchi AM; Efficace F;
Selecting ?-thalassemia Patients for Gene Therapy: A Decision-making Algorithm. in HemaSphere / Hemasphere. 2021 Apr 29;5(5):e555. doi: 10.1097/HS9.0000000000000555. eCollection 2021 May.
2021
ASL Asti
AOU San Luigi di Orbassano
Marchetti M; Pinto V; Rigano P; Origa R; Longo F; Graziadei G; De Franceschi L; Casale M; Baronciani D; Gigante A; Forni GL;
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group. in Hematological oncology / Hematol Oncol. 2021 Aug;39(3):326-335. doi: 10.1002/hon.2861. Epub 2021 Mar 26.
2021
ASL Asti
AOU Città della Salute di Torino
AOU Novara
Foà R; Cuneo A; Vignetti M; Gentile M; Montillo M; Marchetti M; Mauro FR; Crea E; Marasca R; Quaglia FM; Laurenti L; Molinari AL; Paolini R; Pietrasanta D; Sportoletti P; Varettoni M; Farina L; Murru R; Gaidano G; Cibien F; Vitagliano O; Coscia M; Zamprogna G; Visentin A; Reda G; Arena V; Cavazzini F; Piciocchi A; Rigolin GM; et alii...
2021
ASL Asti
Visentin A; Pravato S; Mauro FR; Pietrasanta D; Fresa A; Vitale C; Ciolli S; Cassin R; Cibien F; Sportoletti P; Gentile M; Rigolin GM; Quaglia FM; Murru R; Gozzetti A; Molica S; Marchetti M; Scarfò L; Guardalben E; Avitabile A; Reda G; Coscia M; Laurenti L; Pizzolo G; Semenzato G; Foà R; Cuneo A; Trentin L;
Selecting ?-Thalassemia Patients for Gene Therapy: A Decision-making Algorithm in HemaSphere
2021
ASL Asti
Baronciani D; Casale M; De Franceschi L; Graziadei G; Longo F; Origa R; Rigano P; Pinto V; Marchetti M; Gigante A; Iolascon A; Forni GL;
Selecting ?-Thalassemia Patients for Gene Therapy: A Decision-making Algorithm in HemaSphere
2021
ASL Asti
Baronciani D; Casale M; De Franceschi L; Graziadei G; Longo F; Origa R; Rigano P; Pinto V; Marchetti M; Gigante A; Iolascon A; Forni GL;
Frontline Siltuximab and Rituximab in TAFRO syndrome: A case report. in European journal of haematology / Eur J Haematol. 2020 Oct;105(4):505-507. doi: 10.1111/ejh.13473. Epub 2020 Jul 16.
2020
ASL Asti
Marchetti M; Feyles E; Zinzani P;
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study. in Cancer medicine / Cancer Med. 2020 Nov;9(22):8468-8479. doi: 10.1002/cam4.3470. Epub 2020 Sep 24.
2020
ASL Asti
AOU Città della Salute di Torino
Foà R; Ghia P; Cucci R; Vignetti M; Cavallari M; Cimino G; Ferrarini I; de la Serna J; Medina Perez A; Mauro FR; Di Raimondo F; Coscia M; Molica S; Farina L; Doubek M; Gaidano G; Ilariucci F; Marchetti M; Tedeschi A; Spacek M; Trentin L; Billio A; Roeker L; Orlandi EM; Ujjani CS; Shah NN; Sehgal AR; Schuster SJ; Pu JJ; et alii...
Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study. in Blood cancer journal / Blood Cancer J. 2020 May 18;10(5):58. doi: 10.1038/s41408-020-0326-1.
2020
ASL Asti
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
Larocca A; Romano A; Sonneveld P; Ria R; Musto P; Liberati AM; Offidani M; Giuliani N; Marchetti M; Mosca-Siez ML; de Fabritiis P; Gobbi M; Ballanti S; Cellini C; Grasso M; Monaco F; Ronconi S; Pescosta N; Di Lullo G; Capra A; Belotti A; Petrucci MT; Boccadoro M; Zambello R; Mina R;
Second cancers in MPN: Survival analysis from an international study. in American journal of hematology / Am J Hematol. 2020 Mar;95(3):295-301. doi: 10.1002/ajh.25700. Epub 2019 Dec 22.
2020
ASL Asti
AOU Città della Salute di Torino
AOU Novara
Iurlo A; Cattaneo D; Finazzi G; Bonifacio M; Scaffidi L; Patriarca A; Rumi E; Casetti IC; Stephenson C; Guglielmelli P; Elli EM; Palova M; Rapezzi D; Erez D; Gomez M; Wille K; Perez-Encinas M; Lunghi F; Angona A; Fox ML; Beggiato E; Benevolo G; Carli G; Barbui T; Vannucchi AM; Rambaldi A; Alvarez-Larran A; De Stefano V; Griesshammer M; et alii...
Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study. in HemaSphere / Hemasphere. 2020 Jun 8;4(3):e395. doi: 10.1097/HS9.0000000000000395. eCollection 2020 Jun.
2020
ASL Asti
Visentin A; Nasillo V; Marchetti M; Ferrarini I; Paolini R; Sancetta R; Rigolin GM; Cibien F; Riva M; Briani C; Marinello S; Piazza F; Gherlinzoni F; Krampera M; Bassan R; Cuneo A; Luppi M; Semenzato G; Marasca R; Trentin L;
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study. in Blood / Blood. 2020 Jan 30;135(5):381-386. doi: 10.1182/blood.2019002614.
2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
Barbui T; Rambaldi A; Alvarez-Larran A; Vannucchi AM; Marchetti M; Griesshammer M; Isfort S; Recasens V; McMullin MF; Tieghi A; Cacciola R; Benevolo G; Carli G; Fox ML; Beggiato E; Angona A; Perez-Encinas M; Lunghi F; Wille K; Gomez M; Erez D; Rapezzi D; Palova M; Guglielmelli P; Elli EM; Stephenson C; Casetti IC; Rumi E; Patriarca A; et alii...
Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report. in Blood / Blood. 2020 Aug 6;136(6):763-766. doi: 10.1182/blood.2020006854.
2020
ASL Asti
AOU Città della Salute di Torino
AOU Novara
Foà R; Laurenti L; Marasca R; Mauro FR; Trentin L; Gattei V; Ibatici A; Orsucci L; Rigolin GM; Pietrasanta D; Re F; De Paoli L; Marchetti M; Varettoni M; Quaglia FM; Reda G; Scarfò L; Cuneo A;
Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirin. in Leukemia / Leukemia. 2020 Apr;34(4):1208-1209. doi: 10.1038/s41375-019-0616-4. Epub 2019 Nov 7.
2020
ASL Asti
Barbui T; Ghirardi A; Vannucchi AM; Marchetti M; De Stefano V;
HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Apr;105(4):1042-1054. doi: 10.3324/haematol.2019.217430. Epub 2019 Jul 9.
2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
Coscia M; Foà R; Massaia M; Gaidano G; Bernardi R; Gattei V; Zenz T; Mauro FR; Del Poeta G; Laurenti L; Omedè P; Kodipad AA; Marchetti M; Bonello L; Magliulo D; Bo MD; Pozzato G; Rossi D; Bomben R; Riganti C; Salvetti C; Kopecka J; Todaro M; Vitale C; Griggio V; Boccadoro M;
Worldwide Examination of Patients with CLL Hospitalized for COVID-19 in Blood
2020
ASL Asti
Roeker LE; Scarfo L; Chatzikonstantinou T; Abrisqueta P; Eyre TA; Cordoba R; Muntañola Prat A; Villacampa G; Leslie LA; Koropsak M; Quaresmini G; Allan JN; Furman RR; Bhavsar EB; Pagel JM; Hernandez-Rivas JA; Patel K; Motta M; Bailey N; Miras F; Lamanna N; Alonso R; Osorio-Prendes S; Vitale C; Kamdar M; Baltasar P; Österborg A; Hanson L; Baile M; et alii...
2020
ASL Asti
Visentin A; Mauro FR; Pietrasanta D; Fresa A; Vitale C; Ciolli S; Cassin R; Cibien F; Sportoletti P; Gentile M; Rigolin GM; Quaglia FM; Murru R; Gozzetti A; Molica S; Marchetti M; Scarfo L; Reda G; Coscia M; Laurenti L; Pizzolo G; Semenzato G; Foà R; Cuneo A; Trentin L;
2020
ASL Asti
ASL Biella
Ferrero S; Drandi D; Zibellini S; Ferrante M; Candido C; Marcheselli L; Gilestro M; Picone C; Dogliotti I; Defrancesco I; Ferrari A; Merli M; Zamprogna G; Laurenti L; Tomasetti S; Cencini E; Loseto G; Marino D; Marchetti M; Re F; Sica A; Olivieri J; Puig N; Ratotti S; Cavallo F; Arcaini L; Boccadoro M; Garcia-Sanz R; Varettoni M; et alii...
HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia in Haematologica
2020
ASL Asti
Griggio V; Vitale C; Todaro M; Riganti C; Kopecka J; Salvetti C; Bomben R; Bo MD; Magliulo D; Rossi D; Pozzato G; Bonello L; Marchetti M; Omedè P; Kodipad AA; Laurenti L; Poeta GD; Mauro FR; Bernardi R; Zenz T; Gattei V; Gaidano G; Foà R; Massaia M; Boccadoro M; Coscia M;
2020
ASL Asti
Del Giudice I; Rigolin GM; Bardi A; Melandri A; Cavallari M; Raponi S; Ilari C; Cafforio L; Piciocchi A; Arena V; Fabri S; Albano F; Nanni M; Molica S; Reda G; Sportoletti M; Trentin L; Marchetti M; Peragine N; Mariglia P; Vignetti M; Mauro FR; Guarini A; Foà R; Cuneo A;
2020
ASL Asti
Ferrante M; Ferrero S; Drandi D; Zibellini S; Candido C; Marcheselli L; Gilestro M; Picone C; Dogliotti I; Defrancesco I; Ferrari A; Merli M; Zamprogna G; Laurenti L; Tomassetti S; Cencini E; Loseto G; Marino D; Marchetti M; Re F; Sica A; Olivieri J; Puig N; Rattotti S; Cavallo F; Arcaini L; Boccadoro M; Garcia Sanz R; Varettoni M; et alii...
HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia in Haematologica
2020
ASL Asti
Griggio V; Vitale C; Todaro M; Riganti C; Kopecka J; Salvetti C; Bomben R; Bo MD; Magliulo D; Rossi D; Pozzato G; Bonello L; Marchetti M; Omedè P; Kodipad AA; Laurenti L; Poeta GD; Mauro FR; Bernardi R; Zenz T; Gattei V; Gaidano G; Foà R; Massaia M; Boccadoro M; Coscia M;
HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia in Haematologica
2020
ASL Asti
Griggio V; Vitale C; Todaro M; Riganti C; Kopecka J; Salvetti C; Bomben R; Bo MD; Magliulo D; Rossi D; Pozzato G; Bonello L; Marchetti M; Omedè P; Kodipad AA; Laurenti L; Poeta GD; Mauro FR; Bernardi R; Zenz T; Gattei V; Gaidano G; Foà R; Massaia M; Boccadoro M; Coscia M;
Infection control in patients treated for chronic lymphocytic leukemia with ibrutinib or idelalisib: recommendations from Italian society of hematology. in Leukemia research / Leuk Res. 2019 Jun;81:88-94. doi: 10.1016/j.leukres.2019.04.016. Epub 2019 May 2.
2019
ASL Asti
Zinzani PL; Rambaldi A; Gaidano G; Girmenia C; Marchetti M; Pane F; Tura S; Barosi G;
Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study. in Leukemia / Leukemia. 2019 Aug;33(8):1996-2005. doi: 10.1038/s41375-019-0487-8. Epub 2019 May 29.
2019
ASL Asti
AOU Città della Salute di Torino
AOU Novara
Alvarez-Larran A; Finazzi G; Vannucchi AM; Griesshammer M; Recasens V; Marchetti M; Cacciola R; McMullin MF; Tieghi A; Carli G; Beggiato E; Benevolo G; Fox ML; Lunghi F; Angona A; Wille K; Perez-Encinas M; Gomez M; Erez D; Palova M; Bertolotti L; Elli EM; Guglielmelli P; Casetti IC; Stephenson C; Patriarca A; Rumi E; Bonifacio M; Scaffidi L; et alii...
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib. in British journal of haematology / Br J Haematol. 2018 Sep;182(5):701-704. doi: 10.1111/bjh.15450. Epub 2018 Jul 9.
2018
ASL Asti
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara
Ferrero D; Boccadoro M; Mezzabotta M; Marchetti M; Lanzarone G; Cerrano M; Frairia C; Pugliese N; Beggiato E; Martinelli V; Palumbo GA; Elli EM; Cilloni D; Crisà E;
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet. in Leukemia / Leukemia. 2018 May;32(5):1057-1069. doi: 10.1038/s41375-018-0077-1. Epub 2018 Feb 27.
2018
ASL Asti
Barbui T; Tefferi A; Vannucchi AM; Passamonti F; Silver RT; Hoffman R; Verstovsek S; Mesa R; Kiladjian JJ; Hehlmann R; Reiter A; Cervantes F; Harrison C; Mc Mullin MF; Hasselbalch HC; Koschmieder S; Marchetti M; Bacigalupo A; Finazzi G; Kroeger N; Griesshammer M; Birgegard G; Barosi G;
Lymphoproliferative disorders in patients with chronic myeloproliferative neoplasms: A systematic review. in American journal of hematology / Am J Hematol. 2018 May;93(5):698-703. doi: 10.1002/ajh.25049. Epub 2018 Feb 10.
2018
ASL Asti
Marchetti M; Carobbio A; Capitoni E; Barbui T;
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study. in Haematologica / Haematologica. 2018 Jul;103(7):1209-1217. doi: 10.3324/haematol.2018.189837. Epub 2018 Apr 19.
2018
ASL Asti
AOU Città della Salute di Torino
AOU Novara
Ghia P; Moreno C; Foà R; de la Serna J; Vignetti M; Kennedy B; Bowles KM; Eyre TA; Schuh A; Smolej L; Montillo M; Cortelezzi A; Ciolli S; Forconi F; Gonzalez M; Gaidano G; Re F; Molica S; Marchetti M; Ilariucci F; Meneghini V; Chiarenza A; Marasca R; Billio A; Visco C; Amendola A; Mauro FR; Galieni P; Orlandi EM; et alii...
Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study. in Blood / Blood. 2018 Aug 2;132(5):547-550. doi: 10.1182/blood-2018-03-835413. Epub 2018 Jun 13.
2018
ASL Asti
Rossi G; Gramegna D; Paoloni F; Fattizzo B; Binda F; D'Adda M; Farina M; Lucchini E; Mauro FR; Salvi F; Marchetti M; Fazi P; Zaja F; Barcellini W;
Cost-effectiveness of kinase inhibitors for hematologic malignancies: a systematic and critical review. in Expert review of pharmacoeconomics & outcomes research / Expert Rev Pharmacoecon Outcomes Res. 2017 Oct;17(5):469-480. doi: 10.1080/14737167.2017.1366858. Ep
2017
ASL Asti
Marchetti M;
Identification of new BMP6 pro-peptide mutations in patients with iron overload. in American journal of hematology / Am J Hematol. 2017 Jun;92(6):562-568. doi: 10.1002/ajh.24730. Epub 2017 Apr 29.
2017
ASL Asti
AOU San Luigi di Orbassano
Delledonne M; Olivieri O; Suku E; Giorgetti A; Xumerle L; Roetto A; Marchetti M; De Gobbi M; Badar S; Busti F; Rizzi M; Marchi G; Castagna A; Piubelli C; Girelli D;
Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations. in Leukemia / Leukemia. 2017 Apr;31(4):882-888. doi: 10.1038/leu.2016.283. Epub 2016 Oct 14.
2017
ASL Asti
Marchetti M; Barosi G; Cervantes F; Birgegård G; Griesshammer M; Harrison C; Hehlmann R; Kiladjian JJ; Kröger N; McMullin MF; Passamonti F; Vannucchi A; Barbui T;
Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a systematic and qualitative review. in Expert review of pharmacoeconomics & outcomes research / Expert Rev Pharmacoecon Outcomes Res. 2016;16(2):221-35. doi: 10.1586/14737167.2016.1147351. Epub 20
2016
ASL Asti
Liberato NL; Marchetti M;
Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation guidelines for the management of indolent, nonfollicular B-cell lymphoma (marginal zone, lymphoplasmacytic, and small lymphocytic lymphoma). in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2015 Feb;15(2):75-85. doi: 10.1016/j.clml.2014.07.002. Epub 2014 Jul 15.
2015
ASL Asti
AO Ordine Mauriziano
AOU Città della Salute di Torino
Tura S; Marchetti M; Rambaldi A; Vitolo U; Billio A; Arcaini L; Baldini L; Barosi G; Tarella C; Zinzani PL;
Kinetics of the use of cryopreserved autologous stem cell grafts: a GITMO-SIDEM survey. in Cytotherapy / Cytotherapy. 2014 Jan;16(1):101-10. doi: 10.1016/j.jcyt.2013.07.001. Epub 2013 Oct 26.
2014
ASL Asti
Olivieri J; Pierelli L; Introna M; Accorsi P; Bosi A; Perseghin P; Risso M; Pandolfi A; Mancini S; Marchetti M; Dal Pozzo S; Gotti E; Rambaldi A; Leoni P; Olivieri A;
Biological therapies in Crohn's disease: are they cost-effective? A critical appraisal of model-based analyses. in Expert review of pharmacoeconomics & outcomes research / Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):815-24. doi: 10.1586/14737167.2014.957682. Epub
2014
ASL Asti
Marchetti M; Liberato NL;
Cost-effectiveness analysis of top-down versus step-up strategies in patients with newly diagnosed active luminal Crohn's disease. in The European journal of health economics : HEPAC : health economics in prevention and care / Eur J Health Econ. 2013 Dec;14(6):853-61. doi: 10.1007/s10198-012-0430-7. Epub 2012 Sep 14.
2013
ASL Asti
Marchetti M; Liberato NL; Di Sabatino A; Corazza GR;